Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the core symptoms such as bradykinesia, resting tremor, rigidity and postural instability. Currently, pharmacotherapy and surgical approaches for the treatments of PD can only improve the neurological symptoms. Therefore, to search neuroprotective therapies using pharmacological and nonpharmacological approaches could be important to delay the progression of pathogenesis in PD. Coenzyme Q 10 (CoQ 10 ) is a component of the electron transport chain as well as an important antioxidant in mitochondrial and lipid membranes. The central role of CoQ 10 in two areas implicated in the pathogenesis of PD, mitochondrial dysfunction and oxidative damages, suggest that it may be useful for treatment to slow the progression of PD. The neuroprotective eŠect of CoQ 10 has been reported in several in vivo and in vitro models of neurodegenerative disorders. Although CoQ 10 attenuated the toxin-induced reduction of dopamine content and tyrosine hydroxylase-immunoreactive neurons in the striatum of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model, it is still unknown how this nutrition aŠects the mitochondrial function. We demonstrated that oral administration of CoQ 10 signiˆcantly attenuated the loss of dopaminergic nerve terminals induced by MPTP treatment. Furthermore, our experimental data indicate that an inhibition of mitochondrial cytochrome c release is one of the primary targets for CoQ 10 and may lead to a potent neuroprotection.
. Immunoisolation of Dopaminergic Synaptosomes in Mice
(A) Striatal crude synaptosomes fractions were prepared from mouse striatum. Immunoisolation was performed using Dynabreads coated with DAT-loop antibody, nonspeciˆc rabbit IgG or antibody pre-absorbed with antigenic peptides from prepared crude synaptosomes. The crude synaptosomes fraction (10 mg) and beads-bound fraction were evaluated by Western blot analysis using antibodies against N-terminal of DAT, actin, synaptophysin, SNAP-25 and GAD67. (B) A typical morphology of synaptosomes in striatal crude synaptosomes fraction and beads-bound fraction using electron microscopy. Mt: mitochondrion; Sv: synaptic vesicles. Scale bar, 500 nm. 
